DA32 Life Science Tech Acquisition Corp. Quarterly Income Tax Expense (Benefit) in USD from Q3 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
DA32 Life Science Tech Acquisition Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2021 to Q1 2023.
  • DA32 Life Science Tech Acquisition Corp. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $329K.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $329K +$329K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q3 2022 $192K +$192K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.